The recent J&J case is merely the tip of an intricate iceberg. Beyond the surface, a complex web of systemic issues impacts patients and demands our unwavering attention. As professionals in this field, let's seize the momentum generated by the J&J case to serve as a catalyst for change. Athletes often talk about "stacking good days on top of each other" to achieve greatness. Similarly, let's stack good practices within our industry. Together, we can drive positive transformation. Here are some of our best practices: https://lnkd.in/gHugBvH5
At Borislow, our priority is remaining transparent and keeping you informed. In response to the recent Johnson & Johnson class action lawsuit, Lewandowski v. Johnson & Johnson, et al., alleging that Johnson & Johnson breached its fiduciary duty under ERISA, we’re taking care to inform our clients of both our consulting approach and the manner in which Borislow is and is not compensated for its placement of PBM arrangements. Our recent memorandum is aimed to inform and educate employer/plan sponsors, while serving as part of our efforts to comply with the broker and consultant disclosure requirements enacted as a part of the Consolidated Appropriations Act (CAA). Read our statement here: https://lnkd.in/gHugBvH5 #Transparency #Borislow #ERISA #Healthcare
